Medical Properties Trust, Inc. (MPT)
NYSE: MPT · Real-Time Price · USD
5.11
-0.02 (-0.39%)
At close: May 29, 2026, 4:00 PM EDT
5.10
-0.01 (-0.14%)
After-hours: May 29, 2026, 4:36 PM EDT
Medical Properties Trust Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Medical Properties Trust stock has a consensus rating of "Hold" and an average price target of $5.79. The average 1-year stock price forecast is 13.31% higher than the current stock price, while the lowest is $5.00 (-2.15%) and the highest is $8.00 (+56.56%).
Price Target: $5.79 (+13.31%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Medical Properties Trust stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 2 | 2 | 3 | 3 | 3 | 3 |
| Hold | 4 | 3 | 3 | 3 | 3 | 3 |
| Sell | 3 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 10 | 8 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Reiterates $8 | Buy | Reiterates | $8 | +56.56% | May 2, 2026 |
| Colliers Securities | Colliers Securities | Buy Maintains $7 → $6.5 | Buy | Maintains | $7 → $6.5 | +27.20% | Apr 30, 2026 |
Unknown Analyst Wells Fargo No rating | Wells Fargo | Sell Maintains $6 → $5 | Sell | Maintains | $6 → $5 | -2.15% | Mar 26, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $4.5 → $5 | Hold | Maintains | $4.5 → $5 | -2.15% | Feb 27, 2026 |
| KeyBanc | KeyBanc | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Feb 20, 2026 |
Financial Forecast
Revenue This Year
1.03B
from 1.07B
Decreased by -4.10%
Revenue Next Year
1.07B
from 1.03B
Increased by 4.68%
EPS This Year
0.11
from -0.46
EPS Next Year
0.15
from 0.11
Increased by 30.36%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.2B | 1.2B | |||
| Avg | 1.0B | 1.1B | |||
| Low | 925.8M | 917.5M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 9.3% | 20.7% | |||
| Avg | -4.1% | 4.7% | |||
| Low | -13.5% | -10.6% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 0.15 | 0.22 |
| Avg | 0.11 | 0.15 |
| Low | 0.09 | 0.05 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | - | 94.9% |
| Avg | - | 30.4% |
| Low | - | -56.7% |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.